# Access Consortium
> The Access Consortium is an international collaboration among regulatory authorities from the UK, Australia, Canada, Singapore, and Switzerland. It aims to streamline the market authorization process for new active substances (NASWSI) and biosimilars (BSWSI) by facilitating work-sharing assessment procedures, reducing duplication, and promoting regulatory cooperation.
- URL: https://optimly.ai/brand/access-consortium
- Logo: https://logo.clearbit.com/accessconsortium.info
- Slug: access-consortium
- BAI Score: 33/100
- Archetype: Incumbent
- Category: Regulatory Affairs
- Last Analyzed: August 9, 2026
## Buyer Intent Signals
Problems: Individual National Regulatory Submissions: Instead of participating in the Access Consortium's work-sharing, a pharmaceutical company could opt to submit full, independent applications to each nation | Regulatory Affairs Consultancy Services: Companies can engage specialized regulatory affairs consultancies to manage and navigate the complexities of multi-jurisdictional drug approval processes, whet | Limited Market Authorization Scope: A company might choose to limit the market authorization of its new active substance or biosimilar to fewer countries, or only a single primary market, to avoid the
Solutions: Access Consortium New Active Substance Work-Sharing | Access Consortium biosimilar application process | NASWSI operational procedures | How to apply for Access Consortium | Access Consortium participating countries